Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Omeros (OMER) to Offer $40M in Common Stock
-
Omeros Announces Public Offering of Common Stock
-
CytoSorbents Achieves Fourth Consecutive Quarter of Record CytoSorb® Sales
-
Arrowhead Research (ARWR) Prices $45M Private Stock Offering at $5.90/Share
-
Arrowhead Pharmaceuticals Prices $45 Million Private Offering
-
Fibrocell Announces Proposed Public Offering of Common Stock and Warrants
-
Celldex Reports Second Quarter 2016 Results
-
Vista Gold Corp. Completes Previously Announced US$17.3 Million Bought Deal Offering of Units
-
Cantor Fitzgerald Upgrades TrovaGene (TROV) to Buy
-
Aurinia Reports Second Quarter 2016 Financial Results and Operational Highlights
-
Cantor Fitzgerald Downgrades Shutterstock (SSTK) to Hold
-
Helix Financial Systems Adds Wedbush Securities as Client for its Repo Collateral Management Services
-
Strong U.S. employment report brightens economic outlook
-
Cantor Fitzgerald Downgrades The Rubicon Project, Inc. (RUBI) to Hold
-
Vista Gold Corp. Announces US$15 Million Bought Deal Offering of Units
-
Rocket Fuel (FUEL) Announces $50 ATM Offering
-
Rocket Fuel Registration Statement Including At-the-Market Equity Offering
-
Glaukos Corporation (GKOS) Raising PT After Blowing Out Numbers - Cantor Fitzgerald
-
LTC Properties (LTC) Enters $200M Equity Distribution Agreements
-
AngioDynamics (ANGO) Announces 2.25M Common Stock Secondary Offering
-
AngioDynamics Announces Secondary Offering of 2,250,000 Shares of Common Stock by Selling Stockholders
-
Glaukos Corporation (GKOS): Cantor Expecting Upside In 2Q
-
FinTech Acquisition (FNTC) Shareholders Approve CardConnect Merger Agreement
-
FinTech Acquisition Corp. Shareholders Approve Definitive Merger Agreement with CardConnect
-
Cantor Fitzgerald Downgrades Equity Residential (EQR) to Hold
-
Orchid Island Capital Announces Second Quarter 2016 Results
-
Cantor Fitzgerald Downgrades Seattle Genetics (SGEN) to Hold
-
Rambler Metals & Mining PLC: Director / PDMR Shareholding - CORRECTION
-
Remarks as Prepared for Delivery by Lauren Manning
-
SPEECH EXCERPTS: Select Remarks from Tuesday Night's Program at the Democratic National Convention
-
Rick Miller and Randall Miles Join eXp World Holdings Board of Directors
-
Cantor Fitzgerald Downgrades Relypsa, Inc. (RLYP) to Hold
-
Gladstone Commercial Corporation Reports Results for the Second Quarter Ended June 30, 2016
-
Streetinsider.com's Hot Lunchtime Reads 7/25: (TRP) (WHR) (ALDR) (TBRA)
-
Tobira Therapeutics (TBRA) PT Cut to $19 at Cantor Fitzgerald; Keeps 'Buy'
-
Aurinia Establishes At-The-Market Facility
-
Conyers Park Acquisition Corp. Announces Closing of Initial Public Offering
-
PlacementTracker Announces First Half of 2016 ATM Financing League Tables
-
Conyers Park Acquisition Corp. Announces Pricing of $375 Million Initial Public Offering
-
Spark Therapeutics (ONCE): Reiterated Buy After Gene Therapy Panel - Cantor Fitzgerald
-
Orchid Island Capital Announces July 2016 Monthly Dividend and June 30, 2016 Rmbs Portfolio Characteristics
-
'Leprechaun economics' leaves Irish growth story in limbo
-
RespireRx Pharmaceuticals Inc. to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference on July 13, 2016
-
M III Acquisition Corp. Announces Closing Of Initial Public Offering
-
Great Panther Silver completes previously announced US$29.9 million bought deal offering of units
-
Altimmune to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Jounce Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
MannKind Corporation to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
-
CORRECTING and REPLACING Cerus to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13, 2016


